Related Experiment Video
Updated: May 3, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
[Coagulation disorders in the context of cardiac surgery - Clinical basics and mechanism based therapy]
Insights
Perioperative coagulopathy in cardiac surgery often stems from multiple acquired and inherited disorders. Early detection and tailored treatment, aided by point-of-care systems, can significantly improve patient outcomes and reduce transfusions.
Area of Science:
- Cardiology
- Hematology
- Anesthesiology
Background:
- Intra- and postoperative bleeding disorders are frequent complications in cardiac surgery.
- Perioperative coagulopathy typically arises from a complex interplay of acquired and inherited conditions.
- Effective management is crucial for minimizing complications and improving patient prognosis.
Purpose of the Study:
- To outline the differential diagnosis of microvascular bleeding in cardiac surgery.
- To emphasize the importance of timely detection and rigorous treatment of coagulopathies.
- To highlight the role of point-of-care systems and institutional algorithms in managing these disorders.
Main Methods:
- Review of common causes of perioperative coagulopathy.
- Discussion of diagnostic approaches including altered homeostasis and coagulation factor deficiencies.
- Emphasis on utilizing point-of-care testing and evidence-based algorithms.
Main Results:
- Differential diagnosis includes altered homeostasis, impaired primary hemostasis, antithrombotic use, dilutional/consumptive coagulopathy, fibrinolysis, and factor deficiencies.
- Point-of-care systems enable rapid bedside analysis for prompt diagnosis and intervention.
- Individualized, regularly revised algorithms can optimize resource utilization.
Conclusions:
- Timely diagnosis and treatment of perioperative coagulopathy are essential for reducing transfusion needs and preventing reoperations.
- Point-of-care systems facilitate early detection and intervention.
- Structured, adaptable algorithms can lead to more efficient and effective patient management in cardiac surgery.
Abstract:
Intra- and postoperative bleeding disorders are common in cardiac surgery. The etiology of perioperative coagulopathy frequently becomes apparent as a combination of several acquired and inherited disorders. Differential diagnosis of microvascular bleeding include altered homeostasis (e.g. anemia, hypothermia, acidosis, hypocalcemia), impaired primary hemostasis, antithrombotic medication, dilutive and consumptive coagulopathy, fibrinolysis and the absence or deficiency of coagulation factors. Timely detection of underlying pathology and subsequent rigorous treatment has the potential to minimize perioperative transfusion requirements, prevent resternotomy and improve patient outcome remarkably. Point-of-care-systems can provide fast bed-sided analysis, which contribute to early diagnosis and intervention. Individual and regularly revised algorithms, adapted to the individualized institutional infrastructure, may facilitate resource-saving treatment of perioperative coagulopathy.
More Related Videos
04:56Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Venous Thrombosis III: Interprofessional Care
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...